Drug Profile
Research programme: IAP inhibitors - Pharmascience
Alternative Names: AEG-40056; AEG-40057; AEG-40706; AEG-40730Latest Information Update: 20 May 2016
Price :
$50
*
At a glance
- Originator Aegera Therapeutics
- Class Small molecules
- Mechanism of Action Inhibitor of apoptosis protein inhibitors; X-linked inhibitor of apoptosis protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 20 May 2016 No recent reports on development identified - Preclinical for Cancer in Canada (Parenteral)
- 03 Aug 2012 Human Genome Sciences has been acquired by GlaxoSmithKline
- 27 May 2011 Aegera Therapeutics has been acquired by Pharmascience